Popular Articles
Benefits Of Grapefruit

New York Agency Loses Grant To Expand Services For Families Affected By HIV/AIDS
AIDS Community Services of Western New York (ACS), a Buffalo-based agency that provides medical treatment and social services for individuals and families affected by HIV/AIDS, has lost a $288,500 grant from the Junior League of Buffalo that was to be used to expand a primary care center, the Charlotte Business Journal reports. The Junior League of Buffalo cited a contract agreement that said construction was to be completed by Dec. 31, 2008 as the reason for the decision; construction has yet to begin. ACS President Ronald Silverio said the agency will move forward with its expansion plans, although they will be further delayed, and anticipates that they will receive other funding to replace the loss. Since the ACS began planning this project, they have also experienced cuts in state funding, according to the Journal (Drury, Charlotte Business Journal, 6/19).
generic viagra online
ImmunoCellular Therapeutics Reports Additional Data From Promising Brain Cancer Clinical Trial
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) (IMUC), a biotechnology company, presented promising clinical data from a Phase I trial evaluating ICT-107, the company"s dendritic cell-based cancer vaccine product candidate for the treatment of glioblastoma. These data were reported at the American Society of Clinical Oncology Meeting in Orlando, Florida (Abstract #2032), and supplement the preliminary data from the completed clinical trial that the Company reported in December 2008.
News of the day
Novel Peripheral IV Catheter: Telesso Technologies Wins Popular Science Invention Award
Telesso Technologies Limited (ASX: TEO), a global healthcare company, has announced the FDA-approved guide wire-assisted peripheral IV catheter it is developing with Vascular Pathways, Inc., has been honored with the Popular Science Invention Award.
Diagnostics

UK To Play Lead Role In European Fight Against Dementia

The UK will play a leading role in coordinated European action to tackle dementia from. A new initiative launched by the European Commission has adopted proposals to tackle Alzheimer"s disease, dementias and other neurodegenerative conditions. The UK is one of ten countries that will lead research aimed at tackling shared health and social care problems. According to the Commission there are over seven million people with Alzheimer"s disease and related disorders in Europe and it is predicted that this number will double in the next 20 years. Today"s actions mark new steps both in the Commission"s "Europe for Patients campaign" and the new approach of Joint Programming in research. Dr Susanne Sorensen, Head of Research, Alzheimer"s Society says, "Building on successful high impact dementia research, the UK will play a critical role in this initiative, leading the fight to defeat dementia. By uniting to find a cause, cure and fund care, we can galvanise our efforts and offer hope to millions of people. "But while Europe strives forward, the UK government still lags behind the US, Germany and France in providing dementia research funding and there is still no specifically targeted dementia research funding. Yesterday the government promised to develop a strategy for investment in dementia research. It must make good on its promises or we will all pay the price." In an open letter to the government yesterday, 31 leading dementia researchers united to call for a national plan for dementia research and a tripling of current investment. The letter coincides with a unique ministerial research summit on dementia which stated the importance of increasing research funding spent on dementia. Experts agree the UK must follow the French model for dementia research which provides a focussed structure to support the full breadth of cause, cure and care research. Alzheimer"s Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):